Some Insurance Co-Payments Rise for Cancer Drugs
Many cancer patients will be forced to pay a significantly larger part of their prescription drug costs because of a new pricing system adopted by health insurance companies, according to a New York Times article, "Co-Payments Go Way Up for Drugs With High Prices," published on April 14, 2008. The pricing system requires people who buy some high-priced medications to pay 20% to 33% of the cost, rather than a traditional fixed co-pay of $10 to $30. The system began with Medicare drug plans and is spreading through private insurance plans.
Related Resources
- Learn more about health insurance, and where you can turn for help with insurance issues, in our publication, "What Cancer Survivors Need to Know About Health Insurance."
- Learn where to turn for financial assistance in “Finding Ways to Pay for Care,” a module in our Cancer Survival Toolbox.
Speak Up to Make a Difference
- Share your story so that your Survivor Profile may be featured on our site.
- Comment on this article and read what others have said below.
Leave a Comment
